Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Jill S Menell und 5 weiteren Autor:innen. Beteiligte Einrichtung: St. Joseph's Children's Hospital, Paterson, New Jersey, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hydroxyurea, Duffy Blood-Group System, Antisickling Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Duffy null phenotype is common in people of African ancestry and is associated with lower baseline white blood cell (WBC) and neutrophil counts. We evaluated whether the presence of the Duffy null phenotype had any association with neutropenia in our patients with sickle cell disease on hydroxyurea (HU). We found a statistically significant difference ( p = 0.006) in HU maximum tolerated dose (MTD) in patients with Duffy null phenotype compared with Duffy‐positive individuals. Our study suggests that careful dose escalation is warranted in Duffy‐null individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- St. Joseph's Children's Hospital, Paterson, New Jersey, USA.
- St. George's University School of Medicine, True Blue, Grenada.
ORCID-Profile: Jill S Menell
Zitieren
APA
Menell, J. S., Jackson, S. R., Kahn, A. R., Woolbright, W. C., Schwartz, L. Y., & Norko, J. (2025). Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31693
Vancouver
Menell JS, Jackson SR, Kahn AR, Woolbright WC, Schwartz LY, Norko J. Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31693
BibTeX
@article{Menell2025,
author = {Menell, Jill S and Jackson, S Raelle and Kahn, Alissa R and Woolbright, William C and Schwartz, Leya Y and Norko, John},
title = {Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31693}
}
EUVIMED